LEUKOCYTE DEPLETION IN LABILE BLOOD PRODUCTS

被引：0
|
作者：
GEROTA, J
CAVALIER, J
MASSE, M
WALLER, W
BIDET, ML
机构：
[1] CTR NATL TRANSFUS SANGUINE, F-91943 LES ULIS, FRANCE
[2] CTR REG TRANSFUS BESANCON, BESANCON, FRANCE
[3] CTR REG TRANSFUS STRASBOURG, F-67085 STRASBOURG, FRANCE
[4] CTR REG TRANSFUS ANGERS, F-49021 ANGERS, FRANCE
来源：
REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE | 1987年 / 30卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：109 / +
页数：1
相关论文
共 50 条
  • [41] Leukocyte and Platelet Depletion Improves Blood Flow and Function in a Renal Transplant Model
    Yates, Phillip J.
    Hosgood, Sarah A.
    Nicholson, Michael L.
    JOURNAL OF SURGICAL RESEARCH, 2012, 172 (01) : 159 - 164
  • [42] Leukocyte depletion and recovery with white blood cell sterile acrodisc® syringe filter
    Nicholson, E.
    Singh, S.
    Gordon, A.
    Puddy, L.
    Fuentes, H. Gonzalez
    Lobete, M. Martinez
    CYTOTHERAPY, 2020, 22 (05) : S153 - S154
  • [43] Limited capacity of leukocyte depletion filters to remove tumor cells contaminating blood
    Altmeppen, J
    Zimmermann, M
    Thim, A
    Hansen, E
    ANESTHESIOLOGY, 1998, 89 (3A) : U262 - U262
  • [44] Intraoperative blood salvage and leukocyte depletion during liver transplantation with bacterial contamination
    Liang, Ting-Bo
    Li, Jun-Jian
    Li, Dong-Lin
    Liang, Liang
    Bai, Xue-Li
    Zheng, Shu-Sen
    CLINICAL TRANSPLANTATION, 2010, 24 (02) : 265 - 272
  • [45] QUALITY CONTROL OF LEUKOCYTE-REDUCED BLOOD PRODUCTS IN JAPAN
    Shibata, S.
    Saito, S.
    Moriyama, R.
    Miyajima, H.
    Matsumoto, S.
    Morioka, H.
    Kikuchi, H.
    Sekiguchi, E.
    Fukuda, T.
    Mazda, T.
    Tadokoro, K.
    VOX SANGUINIS, 2009, 97 : 31 - 32
  • [46] A comparison of leukocyte depleted blood products to the combination of CMV seronegative and leukocyte depleted blood products for prevention of CMV infection in allogeneic stem cell transplant recipients
    Ljungman, P
    Larsson, K
    Kumlien, G
    Aschan, J
    Barkholt, L
    Lewensohn-Fuchs, I
    Gustavsson, Å
    Ringdén, O
    BONE MARROW TRANSPLANTATION, 2001, 27 : S51 - S51
  • [47] Qualitative assessment of labile blood products prescription in Le Havre Hospital.
    Damais-Cepitelli, A
    Martin, P
    Devos, AM
    Le Gueult, LC
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2001, 8 (02) : 77 - 84
  • [48] Analysis of causes of destruction of labile blood products in health institutions: A multicentric study
    Damais-Cepitelli, A.
    Leo-Kodeli, S.
    Lovi, V.
    Gouezec, H.
    Lassale, B.
    Augey, L.
    Berger, E.
    Betbeze, V.
    Bourcier, V.
    Daurat, G.
    Ducroz, S.
    Huchet, C.
    Le Niger, C.
    Pujol, S.
    Puntous, M.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2018, 25 (04) : 242 - 248
  • [49] Pathogen inactivation in labile blood products transfusion safety and economic impact - Discussion
    Bourel, Michel
    Caen, Jacques
    Dirreimer, Guy
    Vacheron, Andre
    Sansonetti, Philippe
    Michel-Briand, Yvon
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2006, 190 (01): : 186 - 188
  • [50] CONTRIBUTION OF ENZYMATIC TECHNIQUES TO CHEMICAL-TESTING OF STABLE AND LABILE BLOOD PRODUCTS
    REUGE, C
    REVUE FRANCAISE DE TRANSFUSION ET IMMUNO-HEMATOLOGIE, 1985, 28 (01): : 51 - 59
12345